Correlation Between Abcellera Biologics and Celsius Holdings

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Celsius Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Celsius Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Celsius Holdings, you can compare the effects of market volatilities on Abcellera Biologics and Celsius Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Celsius Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Celsius Holdings.

Diversification Opportunities for Abcellera Biologics and Celsius Holdings

-0.52

Correlation Coefficient

Abcellera Biologics  Celsius Holdings

Excellent diversification

The 3 months correlation between Abcellera and Celsius is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Celsius Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celsius Holdings and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Celsius Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celsius Holdings has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Celsius Holdings go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Celsius Holdings

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Celsius Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Abcellera Biologics is 1.19 times less risky than Celsius Holdings. The stock trades about -0.05 of its potential returns per unit of risk. The Celsius Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2,585  in Celsius Holdings on December 30, 2024 and sell it today you would earn a total of  780.00  from holding Celsius Holdings or generate 30.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Abcellera Biologics  vs.  Celsius Holdings

Abcellera Biologics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Abcellera Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Celsius Holdings

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Celsius Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating essential indicators, Celsius Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Abcellera Biologics and Celsius Holdings

The main advantage of trading using opposite Abcellera Biologics and Celsius Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Celsius Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celsius Holdings will offset losses from the drop in Celsius Holdings' long position.

The idea behind Abcellera Biologics and Celsius Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.